Manager, Global Market Access Strategy, Oncology

Overview

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and Med Tech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.

Learn more at

Job Function: Market Access

Job Sub Function: Health Economics Market Access

Job Category: People Leader

All Job Posting Locations: Raritan, New Jersey, United States of America

About Oncology

Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements. Visionaries like you work on teams that save lives by developing the medicines of tomorrow.

Our Oncology team is focused on the elimination of cancer by discovering new pathways and modalities to finding treatments and cures. We lead where medicine is going and need innovators with an unwavering commitment to results.

Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way. Learn more at

Manager, Global Market Access Strategy, Oncology

The Global Commercial Strategy Organization, a group within Janssen Global Services and a member of Johnson & Johnson's family of companies, is recruiting for a Manager, Global Market Access Strategy. This position will be based in Raritan, NJ.

The Global Strategic Market Access Manager, reporting to the Senior Compound Market Access Leader (Sr CMAL), Lung/ST3, will closely collaborate with the SCMAL/CMALs and support the team to develop and drive the market access strategy for the respective product/indication, aligned with the global clinical and commercial strategy. The Global Strategic Market Access Manager must understand the needs of markets and support development of appropriate solutions to ensure launch readiness and Market Access success.

• Partner with Global Market Access teams (Health Economics, PRO, Access Policy, Pricing, RWE & Analytics) to deliver market access strategies for assigned assets.
• Support generation and integration of pricing, payer, health economics, and epidemiology insights to shape value strategies reflecting system, disease, and companion diagnostic needs.
• Develop and execute global market access tactical plans for assigned products.
• Design and oversee health outcomes research—including literature reviews, RWE studies, and cost‑effectiveness or budget‑impact models—to inform decisions and ensure launch readiness, in collaboration with Regional Market Access, RWE teams and Medical Affairs.
• Contribute to global access policy initiatives for assigned areas.
• Monitor scientific, pricing, and reimbursement developments to strengthen value propositions.
• Integrate patient perspectives into access strategies and payer interactions.
• Support education of commercial and R&D teams on market access trends and opportunities.
• Align strategies across regions and countries to enable timely reimbursement and access.
• Support external engagement to ensure clarity on evidentiary requirements with key decision makers.
• Support an engaged Extended Market Access Team (EMAT) through strong communication, best‑practice sharing, and co‑creation.
• Drive cross‑functional alignment across R&D, GCSO, Clinical Development, Commercial, Medical Affairs, and Global Market Access COE for successful launch readiness.
• Oversee study contract and protocol development to ensure timely execution.
• Manage market access budgets to ensure aligned and efficient spending for projects.

• Master’s degree in appropriate field (Science, Economics, Biostatistics, Epidemiology, Health Economics, or Public Health) or a Pharm
  
  D.
• A minimum of 3 years in Health Economics and Outcomes Research or Market Access.
• A good understanding of pharmaceutical commercialization and…